GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Dividends per Share

Poxel (XPAR:POXEL) Dividends per Share : €0.00 (TTM As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Dividends per Share?

Poxel's dividends per share for the six months ended in Dec. 2022 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2022 was 0.00. As of today, Poxel's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


Poxel Dividends per Share Historical Data

The historical data trend for Poxel's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Dividends per Share Chart

Poxel Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Poxel Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Poxel's Dividends per Share

For the Biotechnology subindustry, Poxel's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poxel's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Poxel's Dividend Yield % falls into.



Poxel Dividends per Share Calculation

Dividends paid to per common share.


Poxel  (XPAR:POXEL) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Poxel's Dividend Payout Ratio for the quarter that ended in Dec. 2022 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2022 )/ EPS without NRI (Q: Dec. 2022 )
=0/ -0.476
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poxel Dividends per Share Related Terms

Thank you for viewing the detailed overview of Poxel's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Poxel (XPAR:POXEL) Business Description

Traded in Other Exchanges
N/A
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines